A significant proportion of children who sustain traumatic brain injury will go on to experience disturbance in their academic, emotional, and social functioning. There is a role for medication in the treatment of these late onset changes. This review will focus on the recognition and pharmacological treatment of the most common and most problematic presentations that may follow head injury, and supports the use of stimulant medication for secondary attention-deficit-hyperactivity disorder despite the small evidence base for use in children.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/S0012162206001472 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!